Effects of the calcium channel antagonist amlodipine in cats with surgically induced hypertensive renal insufficiency

American Journal of Veterinary Research

Volumn 63, Issue 6, 2002, Pages 833-839

  Mathur, Sheerin ^a   Syme, Harriet ^a   Brown, Cathy A ^a   Elliot, Jonathan ^a   Moore, Philip A ^a   Newell, Melvin A ^a   Munday, John S ^a   Cartier, L M ^a   Sheldon, S E ^a   Brown, S A ^a  

^a UNIVERSITY OF GEORGIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; AMLODIPINE BESYLATE; CALCIUM CHANNEL BLOCKING AGENT; CREATININE; AMLODIPINE;

ANIMAL EXPERIMENT; ANTIHYPERTENSIVE ACTIVITY; ARTERIAL PRESSURE; ARTICLE; CAT; CONTROLLED STUDY; CORRELATION FUNCTION; DIASTOLIC BLOOD PRESSURE; DRUG EFFECT; ENTERITIS; EUTHANASIA; FEMALE; HYPERTENSION; HYPERTENSION RETINOPATHY; KIDNEY FAILURE; KIDNEY MASS; MALE; MEAN ARTERIAL PRESSURE; NEPHRECTOMY; NEUROLOGICAL COMPLICATION; NONHUMAN; PHYSICAL ACTIVITY; PREVALENCE; PROGNOSIS; PROTEINURIA; PULSE RATE; SYSTOLIC BLOOD PRESSURE; TELEMETRY; ALBUMINURIA; ANIMAL; ANIMAL DISEASE; BLOOD PRESSURE; CAT DISEASE; CYTOCHEMISTRY; HEART RATE; MOTOR ACTIVITY; PATHOLOGY; RANDOMIZATION; RENOVASCULAR HYPERTENSION;

ANIMALIA; FELIS CATUS;

ALBUMINURIA; AMLODIPINE; ANIMALS; BLOOD PRESSURE; CALCIUM CHANNEL BLOCKERS; CAT DISEASES; CATS; FEMALE; HEART RATE; HISTOCYTOCHEMISTRY; HYPERTENSION, RENAL; KIDNEY FAILURE; MALE; MOTOR ACTIVITY; NEPHRECTOMY; RANDOM ALLOCATION; TELEMETRY;

EID: 0036017303     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: 10.2460/ajvr.2002.63.833     Document Type: Article

References (50)

1. Treatment of systemic hypertension in cats with amlodipine besylate
2. Hypertension in cats with chronic renal failure or hyperthyroidism
3. Systemic hypertension in four cats: Ocular and medical findings
4. Spontaneous systemic hypertension in 24 cats
5. Idiopathic hypertension in a cat with secondary hypertensive retinopathy associated with a high salt diet
6. Hypertension and chronic renal failure
7. Ocular disease associated with hypertension in 16 cats
8. The prevalence of retinopathy in cats with systemic hypertension and chronic renal failure or hyperthyroidism
9. Hypertension and renal disease
10. Diagnosis and treatment of systemic hypertension
11. Hypertensive and hypotensive disorders
12. Management of hypertension controls postoperative neurologic disorders after renal transplantation in cats
13. Effect of amlodipine on echocardiographic variables in cats with systemic hypertension
14. Single-nephron adaptations to partial renal ablation in cats
15. Effect of angiotensin-converting enzyme inhibitor benazepril on the progression of chronic renal insufficiency
16. The case for combining angiotensin-converting enzyme inhibitors and calcium channel blockers
17. Amlodipine: A randomized, blinded clinical trial in 9 cats with systemic hypertension
18. Guide for the care and use of laboratory animals
19. Evaluation of single injection method, using iohexol, for estimating glomerular filtration rate in cats and dogs
20. Effects of certain vasoactive agents on the long-term pattern of blood pressure, heart rate, and motor activity in cats
21. Plasma renin activity and angiotensin I and aldosterone concentrations in cats with hypertension associated with chronic renal disease
22. The renin-angiotensin system in cats with chronic renal failure
23. Renin expression in renal ablation
24. Effects of the angiotensin converting enzyme inhibitor benazepril in cats with induced renal insufficiency
25. Hypertensive retinopathy
26. Classification of hypertensive fundus changes and their order of appearance
27. Hypertension: A review of the mechanisms, manifestations and management
28. Feline ophthalmology
29. Fundus
30. Arterial hypertension in two canine siblings: Ocular and systemic manifestations
31. Hypertensive encephalopathy: Mechanisms, clinical features, and treatment
32. The effects of dietary protein restriction and blood pressure control on the progression of chronic renal disease
33. Non-immunologic mechanisms of glomerular injury
34. The role of hemodynamically mediated glomerular injury in the pathogenesis of progressive glomerular sclerosis in aging, renal ablation and intrinsic renal disease
35. Impaired renal autoregulatory ability in dogs with reduced renal mass
36. Controlled clinical evaluation of enalapril in dogs with heart failure: Results of the Co operative Veterinary Enalapril Study Group
37. Acute and short term hemodynamic, echocardiographic, and clinical effects of enalapril maleate in dogs with naturally acquired heart failure: Results of the Invasive Multicenter Prospective Veterinary Evaluation of Enalapril study
38. Effects of enalapril maleate on survival of dogs with naturally acquired heart failure
39. Long-term effects of antihypertensive regimens on renal hemodynamics and proteinuria
40. Treatment of membranoproliferative glomerulonephritis and nephrotic syndrome in a dog with a thromboxane synthetase inhibitor
41. Evaluation of white-coat effect
42. Automated, ambulatory, or conventional blood pressure measurement in pregnancy: Which is the better predictor of severe hypertension?
43. Reproducibility of ambulatory blood pressure measurements in essential hypertension
44. Ambulatory blood pressure of adults in Novosibirsk, Russia: Interim report on a population study
45. Comparison between casual blood pressure and ambulatory blood pressure monitoring parameters in healthy and hypertensive adolescents
46. Telemetric monitoring of blood pressure in freely moving mice: A preliminary study
47. Ambulatory blood pressure monitoring use in hypertension research and clinical practice
48. Clinical value of ambulatory blood pressure monitoring
49. Ambulatory blood pressure in the transition from normo- to microalbuminuria
50. Current role of automated ambulatory blood pressure and self-measured blood pressure determinations in clinical practice